| Central serous chorioretinopathy: towards an evidence-based treatment guideline TJ Van Rijssen, EH Van Dijk, S Yzer, K Ohno-Matsui, JEE Keunen, ... Progress in retinal and eye research 73, 100770, 2019 | 78 | 2019 |
| Half-dose photodynamic therapy versus high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy: the PLACE trial EHC van Dijk, S Fauser, MB Breukink, R Blanco-Garavito, ... Ophthalmology 125 (10), 1547-1555, 2018 | 76 | 2018 |
| Serous retinopathy associated with mitogen-activated protein kinase kinase inhibition (binimetinib) for metastatic cutaneous and uveal melanoma EHC Van Dijk, CML Van Herpen, M Marinkovic, JBAG Haanen, ... Ophthalmology 122 (9), 1907-1916, 2015 | 42 | 2015 |
| Association of a haplotype in the NR3C2 gene, encoding the mineralocorticoid receptor, with chronic central serous chorioretinopathy EHC van Dijk, RL Schellevis, MGJM van Bergen, MB Breukink, L Altay, ... JAMA ophthalmology 135 (5), 446-451, 2017 | 38 | 2017 |
| Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial … MB Breukink, SM Downes, G Querques, EHC van Dijk, AI den Hollander, ... Trials 16 (1), 1-17, 2015 | 33 | 2015 |
| Human iPSC-derived retinas recapitulate the fetal CRB1 CRB2 complex formation and demonstrate that photoreceptors and Müller glia are targets of AAV5 PM Quinn, TM Buck, AA Mulder, C Ohonin, CH Alves, RM Vos, M Bialecka, ... Stem Cell Reports 12 (5), 906-919, 2019 | 25 | 2019 |
| Loss of MAPK pathway activation in post-mitotic retinal cells as mechanism in MEK inhibition-related retinopathy in cancer patients EHC van Dijk, DEM Duits, M Versluis, GPM Luyten, AAB Bergen, ... Medicine 95 (18), 2016 | 23 | 2016 |
| Role of the complement system in chronic central serous chorioretinopathy: a genome-wide association study RL Schellevis, EHC van Dijk, MB Breukink, L Altay, B Bakker, ... JAMA ophthalmology 136 (10), 1128-1136, 2018 | 22 | 2018 |
| Behçet’s disease, hospital-based prevalence and manifestations in the Rotterdam area JH Kappen, EHC van Dijk, M Baak-Dijkstra, PL van Daele, WK Lam-Tse, ... Neth J Med 73 (10), 471-7, 2015 | 22 | 2015 |
| Focal and diffuse chronic central serous chorioretinopathy treated with half-dose photodynamic therapy or subthreshold micropulse laser: PLACE Trial Report No. 3 TJ Van Rijssen, EHC Van Dijk, P Scholz, MB Breukink, R Blanco-Garavito, ... American journal of ophthalmology 205, 1-10, 2019 | 21 | 2019 |
| Central serous chorioretinopathy in primary hyperaldosteronism EHC Van Dijk, MF Nijhoff, EK de Jong, OC Meijer, APJ de Vries, ... Graefe's Archive for Clinical and Experimental Ophthalmology 254 (10), 2033-2042, 2016 | 21 | 2016 |
| Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy D Mohabati, TJ van Rijssen, EHC van Dijk, GPM Luyten, TO Missotten, ... Clinical Ophthalmology (Auckland, NZ) 12, 1061, 2018 | 19 | 2018 |
| Chronic central serous chorioretinopathy as a presenting symptom of Cushing syndrome EHC van Dijk, G Dijkman, NR Biermasz, FM van Haalen, AM Pereira, ... European journal of ophthalmology 26 (5), 442-448, 2016 | 17 | 2016 |
| Reshaping ophthalmology training after COVID-19 pandemic M Ferrara, V Romano, DH Steel, R Gupta, C Iovino, EHC van Dijk, ... Eye 34 (11), 2089-2097, 2020 | 16 | 2020 |
| cushing’s syndrome and hypothalamic–Pituitary–adrenal axis hyperactivity in chronic central serous chorioretinopathy FM Van Haalen, EHC van Dijk, OM Dekkers, MB Bizino, G Dijkman, ... Frontiers in endocrinology 9, 39, 2018 | 16 | 2018 |
| Discrepancy in current central serous chorioretinopathy classification SR Singh, A Matet, EHC Van Dijk, A Daruich, S Fauser, S Yzer, E Peiretti, ... British Journal of Ophthalmology 103 (6), 737-742, 2019 | 15 | 2019 |
| Correlation between redefined optical coherence tomography parameters and best-corrected visual acuity in non-resolving central serous chorioretinopathy treated with half-dose … TJ van Rijssen, D Mohabati, G Dijkman, T Theelen, EK de Jong, ... PloS one 13 (8), e0202549, 2018 | 15 | 2018 |
| Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy TJ van Rijssen, EHC van Dijk, G Dijkman, CJF Boon Graefe's Archive for Clinical and Experimental Ophthalmology 256 (8), 1395-1402, 2018 | 15 | 2018 |
| Efficacy of photodynamic therapy in steroid‐associated chronic central serous chorioretinopathy: a case–control study MB Breukink, D Mohabati, EHC van Dijk, AI den Hollander, EK de Jong, ... Acta ophthalmologica 94 (6), 565-572, 2016 | 14 | 2016 |
| Short-Term findings on optical coherence tomography and Microperimetry in chronic central serous Chorioretinopathy patients treated with half-dose photodynamic therapy EHC van Dijk, G Dijkman, T Theelen, CB Hoyng, CJF Boon Retinal Cases and Brief Reports 12 (4), 266-271, 2018 | 11 | 2018 |
